David Iglesias, MD : Research

Cancer Specialist (Oncologist), Gynecologic Oncologist (Gynecological Cancer Specialist)

4.9

75 ratings 15 reviews

Additional languages:: Spanish

(352) 265-8200 MyUFHealth

Research at a glance

Top areas of exploration

Endometrial Neoplasms , 9 publications
Metformin , 5 publications
Uterine Neoplasms , 4 publications
Carcinoma, Endometrioid , 4 publications

Research activity

24 publications

1,258 citations

Why is this important?

Active clinical trials

Phase 3 Study of sac-TMT Plus Pembrolizumab as 1L Maintenance in pMMR Endometrial Cancer

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. EC is a type of cancer that starts in the tissues inside the uterus (womb) pMMR indicates that…

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: Female

Comparing Two Surgical Procedures in Individuals with Ovarian Cancer+BRCA1 Mutations(SOROCk)

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the…

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 35 Years - 50 Years
Sexes: Female

My publications

24 publications

2017

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Gynecologic oncology

PubMed • Publisher's site

2016

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Gynecologic oncology

PubMed • Publisher's site

2014

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Cancer

PubMed • Publisher's site

2014

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

PubMed • Publisher's site

2014

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Gynecologic oncology

PubMed • Publisher's site

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.